Kalaris Therapeutics Inc (KLRS) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Kalaris Therapeutics Inc (KLRS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $98.0M, listed on NASDAQ, employing roughly 14 people, carrying a beta of 0.15 to the broader market. Kalaris Therapeutics Inc operates as a pharmaceutical company. Led by Andrew Oxtoby, public since 2020-07-30.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for KLRS as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →